Yoshio Terada

9.1k total citations
253 papers, 6.6k citations indexed

About

Yoshio Terada is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Yoshio Terada has authored 253 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 57 papers in Surgery and 49 papers in Nephrology. Recurrent topics in Yoshio Terada's work include Ion Transport and Channel Regulation (20 papers), Chronic Kidney Disease and Diabetes (17 papers) and Acute Kidney Injury Research (16 papers). Yoshio Terada is often cited by papers focused on Ion Transport and Channel Regulation (20 papers), Chronic Kidney Disease and Diabetes (17 papers) and Acute Kidney Injury Research (16 papers). Yoshio Terada collaborates with scholars based in Japan, United States and Germany. Yoshio Terada's co-authors include Fumiaki Marumo, Hiroshi Nonoguchi, Kimio Tomita, Sei Sasaki, Michio Kuwahara, Seiji Inoshita, Taro Horino, Yoshinori Taniguchi, Tomokazu Okado and Yoshiko Shimamura and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Yoshio Terada

234 papers receiving 6.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yoshio Terada 3.3k 1.2k 1.0k 962 915 253 6.6k
Shoji Kagami 1.8k 0.6× 1.2k 1.0× 589 0.6× 585 0.6× 1.2k 1.3× 206 5.9k
Matsuhiko Hayashi 2.5k 0.7× 1.2k 1.0× 582 0.6× 675 0.7× 1.8k 2.0× 203 6.1k
Akira Sugawara 4.7k 1.4× 1.1k 0.9× 1.2k 1.2× 947 1.0× 2.6k 2.9× 294 10.4k
Kenichi Shikata 1.8k 0.5× 1.6k 1.3× 807 0.8× 415 0.4× 775 0.8× 177 6.1k
Barbara J. Ballermann 2.4k 0.7× 896 0.8× 1.4k 1.4× 887 0.9× 2.0k 2.1× 93 6.0k
Ronald G. Tilton 2.8k 0.8× 1.4k 1.2× 3.1k 3.0× 950 1.0× 1.2k 1.3× 127 10.2k
Taiji Matsusaka 2.9k 0.9× 1.9k 1.6× 502 0.5× 599 0.6× 1.3k 1.4× 124 7.4k
Kenichiro Kitamura 2.5k 0.8× 966 0.8× 388 0.4× 726 0.8× 496 0.5× 117 4.9k
Adrian I. Katz 3.3k 1.0× 1.4k 1.2× 715 0.7× 1.3k 1.4× 558 0.6× 126 7.2k
Joseph Satriano 2.0k 0.6× 999 0.8× 938 0.9× 323 0.3× 390 0.4× 72 5.1k

Countries citing papers authored by Yoshio Terada

Since Specialization
Citations

This map shows the geographic impact of Yoshio Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Terada more than expected).

Fields of papers citing papers by Yoshio Terada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Terada. The network helps show where Yoshio Terada may publish in the future.

Co-authorship network of co-authors of Yoshio Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Terada. A scholar is included among the top collaborators of Yoshio Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Terada. Yoshio Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horino, Taro, et al.. (2025). Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy. QJM. 118(4). 306–307. 1 indexed citations
2.
Taniguchi, Yoshinori, Yoshiko Shimamura, Tatsuki Matsumoto, et al.. (2024). Clinical significance of amphiregulin in patients with chronic kidney disease. Clinical and Experimental Nephrology. 28(5). 421–430. 4 indexed citations
3.
Funakoshi, Shogo, Mitsuru Nishiyama, Masahiro Komori, et al.. (2024). Hypopituitarism due to CNS <i>Aspergillus</i> Infection. Internal Medicine. 63(21). 2953–2959. 1 indexed citations
4.
Horino, Taro, Hiroshi Ohnishi, Masahiro Komori, & Yoshio Terada. (2023). Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis exacerbated by clopidogrel bisulphate. Romanian Journal of Internal Medicine. 61(4). 216–221.
5.
Horino, Taro, et al.. (2023). Nephrotic syndrome caused by IgA vasculitis flare up following COVID-19 vaccination. QJM. 116(7). 556–558. 1 indexed citations
6.
Ishihara, Masayuki, Kazu Hamada, Tatsuki Matsumoto, et al.. (2013). Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. American Journal of Physiology-Renal Physiology. 305(4). F495–F509. 177 indexed citations
7.
Terada, Yoshio, Yuto Shimamura, Keisuke Hamada, et al.. (2012). Serum levels of soluble secreted [alpha]-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. 15th International & 14th European Congress of Endocrinology. 29. 17 indexed citations
8.
Zhao, Lifeng, Yasumasa Iwasaki, Mitsuru Nishiyama, et al.. (2012). Liver X Receptor α Is Involved in the Transcriptional Regulation of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene. Diabetes. 61(5). 1062–1071. 15 indexed citations
9.
Horino, Taro, et al.. (2009). A case with spontaneous bladder rupture mimicking acute kidney injury.. PubMed. 72(5). 391–3. 3 indexed citations
10.
Kobayashi, Takayoshi, Yoshio Terada, Hitoshi Kuwana, et al.. (2008). Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney International. 73(11). 1240–1250. 88 indexed citations
11.
Kuwahara, Michio, et al.. (2005). The C-terminal tail of aquaporin-2 determines apical trafficking. Kidney International. 68(5). 1999–2009. 22 indexed citations
12.
Wada, Takehiko, Jeffrey W. Pippin, Yoshio Terada, & Stuart J. Shankland. (2005). The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis. Kidney International. 68(4). 1618–1629. 56 indexed citations
13.
Kuwahara, Michio, Hidetake Kurihara, Tatsuo Sakai, et al.. (2003). Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 C-terminus mutations. Kidney International. 64(1). 2–10. 54 indexed citations
14.
Okado, Tomokazu, Yoshio Terada, Hiroyuki Tanaka, et al.. (2002). Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells. Kidney International. 62(4). 1178–1186. 4 indexed citations
15.
Terada, Yoshio, et al.. (2002). Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney International. 61(1). S94–S98. 87 indexed citations
16.
Okado, Tomokazu, Yoshio Terada, Hiroyuki Tanaka, et al.. (2002). Smad7 mediates transforming growth factor-β–induced apoptosis in mesangial cells. Kidney International. 62(4). 1178–1186. 48 indexed citations
17.
Kuwahara, Michio, Kazuyuki Iwai, Takashi Igarashi, et al.. (2001). Three Families with Autosomal Dominant Nephrogenic Diabetes Insipidus Caused by Aquaporin-2 Mutations in the C-Terminus. The American Journal of Human Genetics. 69(4). 738–748. 109 indexed citations
18.
Nasu, Kimio, Hitoshi Kohsaka, Yoshinori Nonomura, et al.. (2000). Adenoviral Transfer of Cyclin-Dependent Kinase Inhibitor Genes Suppresses Collagen-Induced Arthritis in Mice. The Journal of Immunology. 165(12). 7246–7252. 63 indexed citations
19.
Terada, Yoshio, Seiji Inoshita, Osamu Nakashima, et al.. (1999). Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney International. 56(4). 1258–1261. 49 indexed citations
20.
Terada, Yoshio, Osamu Nakashima, Seiji Inoshita, et al.. (1999). TGF-βbgr-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney International. 56(4). 1378–1390. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026